Dr. Reddy’s Laboratories Ltd Q3 FY2025 consolidated PAT higher at Rs. 1413.3 crores

has reported Consolidated financial results for the period ended December 31, 2024.

Financial Results (Q3 FY2025) - QoQ Comparison

The company has reported total income of Rs. 8358.6 crores during the period ended December 31, 2024 as compared to Rs. 8016.2 crores during the period ended September 30, 2024.

The company has posted net profit / (loss) of Rs. 1413.3 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs. 1255.3 crores for the period ended September 30, 2024.

The company has reported EPS of Rs. 16.94 for the period ended December 31, 2024 as compared to Rs. 15.05 for the period ended September 30, 2024.

Financials	Q3 FY2025	Q2 FY2025	% Change
Total Income	₹8358.6 crs	₹8016.2 crs	4.27%
Net Profit	₹1413.3 crs	₹1255.3 crs	12.59%
EPS	₹16.94	₹15.05	12.56%

Financial Results (Q3 FY2025) - YoY Comparison

The company has reported total income of Rs.8358.6 crores during the period ended December 31, 2024 as compared to Rs.7214.8 crores during the period ended December 31, 2023.

The company has posted net profit / (loss) of Rs.1413.3 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs.1378.9 crores for the period ended December 31, 2023.

The company has reported EPS of Rs.16.94 for the period ended December 31, 2024 as compared to Rs.16.54 for the period ended December 31, 2023.

Financials	Q3 FY2025	Q3 FY2024	% Change
Total Income	₹8358.6 crs	₹7214.8 crs	15.85%
Net Profit	₹1413.3 crs	₹1378.9 crs	2.49%
EPS	₹16.94	₹16.54	2.42%

Financial Results (9 Months Ended FY2025) - YoY Comparison

The company has reported total income of Rs.24047.5 crores during the 9 Months period ended December 31, 2024 as compared to Rs.20833.4 crores during the 9 Months period ended December 31, 2023.

The company has posted net profit / (loss) of Rs.4060.6 crores for the 9 Months period ended December 31, 2024 as against net profit / (loss) of Rs.4261.4 crores for the 9 Months period ended December 31, 2023.

The company has reported EPS of Rs.48.68 for the 9 Months period ended December 31, 2024 as compared to Rs.51.14 for the 9 Months period ended December 31, 2023.

Financials	9 Months Ended FY2025	9 Months Ended FY2024	% Change
Total Income	₹24047.5 crs	₹20833.4 crs	15.43%
Net Profit	₹4060.6 crs	₹4261.4 crs	-4.71%
EPS	₹48.68	₹51.14	-4.81%

Source : Equity Bulls

Keywords

DrReddysLaboratories Q3FY25 9MFY25 Q3FY2025 9MFY2025 ResultUpdate RDY